nodes	percent_of_prediction	percent_of_DWPC	metapath
Thalidomide—NFKB1—ulcerative colitis	0.265	0.586	CbGaD
Thalidomide—TNF—ulcerative colitis	0.0811	0.18	CbGaD
Thalidomide—PTGS1—ulcerative colitis	0.0674	0.149	CbGaD
Thalidomide—PTGS2—ulcerative colitis	0.0385	0.0853	CbGaD
Thalidomide—PTGS2—Olsalazine—ulcerative colitis	0.0373	0.104	CbGbCtD
Thalidomide—PTGS2—Balsalazide—ulcerative colitis	0.0332	0.093	CbGbCtD
Thalidomide—PTGS1—Olsalazine—ulcerative colitis	0.0315	0.0881	CbGbCtD
Thalidomide—PTGS1—Balsalazide—ulcerative colitis	0.0281	0.0785	CbGbCtD
Thalidomide—PTGS2—Mesalazine—ulcerative colitis	0.0266	0.0743	CbGbCtD
Thalidomide—PTGS1—Mesalazine—ulcerative colitis	0.0224	0.0628	CbGbCtD
Thalidomide—CYP1A1—Nicotine—ulcerative colitis	0.0161	0.0451	CbGbCtD
Thalidomide—PTGS2—Triamcinolone—ulcerative colitis	0.0148	0.0415	CbGbCtD
Thalidomide—PTGS2—Sulfasalazine—ulcerative colitis	0.0148	0.0415	CbGbCtD
Thalidomide—CYP1A1—Cholecalciferol—ulcerative colitis	0.0145	0.0404	CbGbCtD
Thalidomide—PTGS2—Betamethasone—ulcerative colitis	0.0127	0.0356	CbGbCtD
Thalidomide—PTGS1—Sulfasalazine—ulcerative colitis	0.0125	0.0351	CbGbCtD
Thalidomide—CYP2E1—Nicotine—ulcerative colitis	0.0124	0.0348	CbGbCtD
Thalidomide—CYP2C19—Nicotine—ulcerative colitis	0.0078	0.0218	CbGbCtD
Thalidomide—CYP3A5—Sulfasalazine—ulcerative colitis	0.00752	0.021	CbGbCtD
Thalidomide—PTGS2—Dexamethasone—ulcerative colitis	0.00741	0.0207	CbGbCtD
Thalidomide—CYP1A2—Nicotine—ulcerative colitis	0.0072	0.0201	CbGbCtD
Thalidomide—CYP2C19—Cholecalciferol—ulcerative colitis	0.007	0.0196	CbGbCtD
Thalidomide—CYP2C9—Nicotine—ulcerative colitis	0.00649	0.0181	CbGbCtD
Thalidomide—CYP1A1—Dexamethasone—ulcerative colitis	0.00626	0.0175	CbGbCtD
Thalidomide—CYP3A5—Hydrocortisone—ulcerative colitis	0.00604	0.0169	CbGbCtD
Thalidomide—CYP2C9—Cholecalciferol—ulcerative colitis	0.00582	0.0163	CbGbCtD
Thalidomide—CYP2C19—Prednisone—ulcerative colitis	0.00485	0.0136	CbGbCtD
Thalidomide—CYP2E1—Dexamethasone—ulcerative colitis	0.00483	0.0135	CbGbCtD
Thalidomide—CYP3A5—Dexamethasone—ulcerative colitis	0.00375	0.0105	CbGbCtD
Thalidomide—CYP2C19—Dexamethasone—ulcerative colitis	0.00303	0.00847	CbGbCtD
Thalidomide—CYP2C9—Dexamethasone—ulcerative colitis	0.00252	0.00704	CbGbCtD
Thalidomide—Pomalidomide—TNF—ulcerative colitis	0.000935	0.354	CrCbGaD
Thalidomide—NFKB1—lymphoid tissue—ulcerative colitis	0.000642	0.0728	CbGeAlD
Thalidomide—NFKB1—digestive system—ulcerative colitis	0.000634	0.072	CbGeAlD
Thalidomide—FGFR2—epithelium—ulcerative colitis	0.000626	0.071	CbGeAlD
Thalidomide—FGFR2—smooth muscle tissue—ulcerative colitis	0.000603	0.0684	CbGeAlD
Thalidomide—CRBN—lymphoid tissue—ulcerative colitis	0.000538	0.0611	CbGeAlD
Thalidomide—CRBN—digestive system—ulcerative colitis	0.000531	0.0603	CbGeAlD
Thalidomide—Lenalidomide—PTGS2—ulcerative colitis	0.000478	0.181	CrCbGaD
Thalidomide—FGFR2—digestive system—ulcerative colitis	0.000476	0.054	CbGeAlD
Thalidomide—NFKB1—liver—ulcerative colitis	0.000472	0.0536	CbGeAlD
Thalidomide—Pomalidomide—PTGS2—ulcerative colitis	0.000444	0.168	CrCbGaD
Thalidomide—PTGS2—Fluocinonide—Budesonide—ulcerative colitis	0.000425	0.247	CbGdCrCtD
Thalidomide—Lenalidomide—ABCB1—ulcerative colitis	0.000406	0.154	CrCbGaD
Thalidomide—CRBN—liver—ulcerative colitis	0.000396	0.0449	CbGeAlD
Thalidomide—Pomalidomide—ABCB1—ulcerative colitis	0.000378	0.143	CrCbGaD
Thalidomide—FGFR2—liver—ulcerative colitis	0.000355	0.0403	CbGeAlD
Thalidomide—CYP1A1—epithelium—ulcerative colitis	0.000226	0.0257	CbGeAlD
Thalidomide—CYP2C19—digestive system—ulcerative colitis	0.000214	0.0243	CbGeAlD
Thalidomide—PTGS2—Fluocinonide—Methylprednisolone—ulcerative colitis	0.000205	0.119	CbGdCrCtD
Thalidomide—PTGS2—Fluocinonide—Dexamethasone—ulcerative colitis	0.000202	0.118	CbGdCrCtD
Thalidomide—PTGS2—Fluocinonide—Betamethasone—ulcerative colitis	0.000202	0.118	CbGdCrCtD
Thalidomide—PTGS1—epithelium—ulcerative colitis	0.000199	0.0226	CbGeAlD
Thalidomide—PTGS2—Fluocinonide—Triamcinolone—ulcerative colitis	0.000197	0.115	CbGdCrCtD
Thalidomide—PTGS1—smooth muscle tissue—ulcerative colitis	0.000192	0.0218	CbGeAlD
Thalidomide—PTGS2—epithelium—ulcerative colitis	0.00019	0.0216	CbGeAlD
Thalidomide—PTGS2—smooth muscle tissue—ulcerative colitis	0.000183	0.0208	CbGeAlD
Thalidomide—CYP1A2—digestive system—ulcerative colitis	0.000175	0.0198	CbGeAlD
Thalidomide—CYP1A1—digestive system—ulcerative colitis	0.000172	0.0196	CbGeAlD
Thalidomide—CYP3A5—digestive system—ulcerative colitis	0.000168	0.0191	CbGeAlD
Thalidomide—CYP2C9—digestive system—ulcerative colitis	0.000166	0.0188	CbGeAlD
Thalidomide—CYP2C19—liver—ulcerative colitis	0.000159	0.0181	CbGeAlD
Thalidomide—CYP2E1—lymphoid tissue—ulcerative colitis	0.000159	0.0181	CbGeAlD
Thalidomide—CYP2E1—digestive system—ulcerative colitis	0.000157	0.0178	CbGeAlD
Thalidomide—PTGS1—digestive system—ulcerative colitis	0.000151	0.0172	CbGeAlD
Thalidomide—PTGS2—lymphoid tissue—ulcerative colitis	0.000146	0.0166	CbGeAlD
Thalidomide—PTGS2—digestive system—ulcerative colitis	0.000145	0.0164	CbGeAlD
Thalidomide—CYP1A2—liver—ulcerative colitis	0.00013	0.0148	CbGeAlD
Thalidomide—CYP1A1—liver—ulcerative colitis	0.000128	0.0146	CbGeAlD
Thalidomide—CYP3A5—liver—ulcerative colitis	0.000126	0.0142	CbGeAlD
Thalidomide—PTGS2—Fluticasone Propionate—Methylprednisolone—ulcerative colitis	0.000124	0.0721	CbGdCrCtD
Thalidomide—CYP2C9—liver—ulcerative colitis	0.000124	0.014	CbGeAlD
Thalidomide—PTGS2—Fluticasone Propionate—Betamethasone—ulcerative colitis	0.000122	0.071	CbGdCrCtD
Thalidomide—PTGS2—Fluticasone Propionate—Dexamethasone—ulcerative colitis	0.000122	0.071	CbGdCrCtD
Thalidomide—PTGS2—Fluticasone Propionate—Triamcinolone—ulcerative colitis	0.000119	0.0693	CbGdCrCtD
Thalidomide—CYP2E1—liver—ulcerative colitis	0.000117	0.0133	CbGeAlD
Thalidomide—PTGS2—liver—ulcerative colitis	0.000108	0.0122	CbGeAlD
Thalidomide—Hyperhidrosis—Prednisolone—ulcerative colitis	3.47e-05	0.000347	CcSEcCtD
Thalidomide—Shock—Hydrocortisone—ulcerative colitis	3.45e-05	0.000345	CcSEcCtD
Thalidomide—Myalgia—Triamcinolone—ulcerative colitis	3.45e-05	0.000344	CcSEcCtD
Thalidomide—Vomiting—Azathioprine—ulcerative colitis	3.45e-05	0.000344	CcSEcCtD
Thalidomide—Nervous system disorder—Hydrocortisone—ulcerative colitis	3.44e-05	0.000344	CcSEcCtD
Thalidomide—Arthralgia—Methylprednisolone—ulcerative colitis	3.44e-05	0.000343	CcSEcCtD
Thalidomide—Myalgia—Methylprednisolone—ulcerative colitis	3.44e-05	0.000343	CcSEcCtD
Thalidomide—Eye disorder—Prednisone—ulcerative colitis	3.44e-05	0.000343	CcSEcCtD
Thalidomide—Anxiety—Methylprednisolone—ulcerative colitis	3.43e-05	0.000342	CcSEcCtD
Thalidomide—Tachycardia—Hydrocortisone—ulcerative colitis	3.43e-05	0.000342	CcSEcCtD
Thalidomide—Rash—Azathioprine—ulcerative colitis	3.42e-05	0.000341	CcSEcCtD
Thalidomide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	3.42e-05	0.000341	CcSEcCtD
Thalidomide—Dermatitis—Azathioprine—ulcerative colitis	3.41e-05	0.000341	CcSEcCtD
Thalidomide—Skin disorder—Hydrocortisone—ulcerative colitis	3.41e-05	0.00034	CcSEcCtD
Thalidomide—Ill-defined disorder—Betamethasone—ulcerative colitis	3.41e-05	0.00034	CcSEcCtD
Thalidomide—Ill-defined disorder—Dexamethasone—ulcerative colitis	3.41e-05	0.00034	CcSEcCtD
Thalidomide—Discomfort—Triamcinolone—ulcerative colitis	3.41e-05	0.00034	CcSEcCtD
Thalidomide—Discomfort—Methylprednisolone—ulcerative colitis	3.4e-05	0.000339	CcSEcCtD
Thalidomide—Headache—Azathioprine—ulcerative colitis	3.4e-05	0.000339	CcSEcCtD
Thalidomide—Hyperhidrosis—Hydrocortisone—ulcerative colitis	3.39e-05	0.000339	CcSEcCtD
Thalidomide—Diarrhoea—Mesalazine—ulcerative colitis	3.38e-05	0.000337	CcSEcCtD
Thalidomide—Dry mouth—Triamcinolone—ulcerative colitis	3.37e-05	0.000336	CcSEcCtD
Thalidomide—Angioedema—Dexamethasone—ulcerative colitis	3.36e-05	0.000335	CcSEcCtD
Thalidomide—Angioedema—Betamethasone—ulcerative colitis	3.36e-05	0.000335	CcSEcCtD
Thalidomide—Anorexia—Hydrocortisone—ulcerative colitis	3.35e-05	0.000334	CcSEcCtD
Thalidomide—Angiopathy—Prednisone—ulcerative colitis	3.34e-05	0.000333	CcSEcCtD
Thalidomide—Confusional state—Methylprednisolone—ulcerative colitis	3.33e-05	0.000332	CcSEcCtD
Thalidomide—Immune system disorder—Prednisone—ulcerative colitis	3.32e-05	0.000331	CcSEcCtD
Thalidomide—Malaise—Betamethasone—ulcerative colitis	3.31e-05	0.000331	CcSEcCtD
Thalidomide—Malaise—Dexamethasone—ulcerative colitis	3.31e-05	0.000331	CcSEcCtD
Thalidomide—Oedema—Triamcinolone—ulcerative colitis	3.31e-05	0.00033	CcSEcCtD
Thalidomide—Vertigo—Betamethasone—ulcerative colitis	3.3e-05	0.000329	CcSEcCtD
Thalidomide—Vertigo—Dexamethasone—ulcerative colitis	3.3e-05	0.000329	CcSEcCtD
Thalidomide—Syncope—Betamethasone—ulcerative colitis	3.3e-05	0.000329	CcSEcCtD
Thalidomide—Syncope—Dexamethasone—ulcerative colitis	3.3e-05	0.000329	CcSEcCtD
Thalidomide—Arrhythmia—Prednisone—ulcerative colitis	3.28e-05	0.000328	CcSEcCtD
Thalidomide—Infection—Triamcinolone—ulcerative colitis	3.28e-05	0.000328	CcSEcCtD
Thalidomide—Hypotension—Hydrocortisone—ulcerative colitis	3.28e-05	0.000327	CcSEcCtD
Thalidomide—Infection—Methylprednisolone—ulcerative colitis	3.28e-05	0.000327	CcSEcCtD
Thalidomide—Dizziness—Mesalazine—ulcerative colitis	3.26e-05	0.000326	CcSEcCtD
Thalidomide—Shock—Triamcinolone—ulcerative colitis	3.25e-05	0.000324	CcSEcCtD
Thalidomide—Insomnia—Prednisolone—ulcerative colitis	3.25e-05	0.000324	CcSEcCtD
Thalidomide—Alopecia—Prednisone—ulcerative colitis	3.25e-05	0.000324	CcSEcCtD
Thalidomide—Shock—Methylprednisolone—ulcerative colitis	3.24e-05	0.000324	CcSEcCtD
Thalidomide—Nervous system disorder—Methylprednisolone—ulcerative colitis	3.23e-05	0.000323	CcSEcCtD
Thalidomide—Loss of consciousness—Betamethasone—ulcerative colitis	3.23e-05	0.000322	CcSEcCtD
Thalidomide—Loss of consciousness—Dexamethasone—ulcerative colitis	3.23e-05	0.000322	CcSEcCtD
Thalidomide—Paraesthesia—Prednisolone—ulcerative colitis	3.23e-05	0.000322	CcSEcCtD
Thalidomide—Tachycardia—Triamcinolone—ulcerative colitis	3.23e-05	0.000322	CcSEcCtD
Thalidomide—Mental disorder—Prednisone—ulcerative colitis	3.22e-05	0.000321	CcSEcCtD
Thalidomide—Nausea—Azathioprine—ulcerative colitis	3.22e-05	0.000321	CcSEcCtD
Thalidomide—Tachycardia—Methylprednisolone—ulcerative colitis	3.22e-05	0.000321	CcSEcCtD
Thalidomide—Skin disorder—Methylprednisolone—ulcerative colitis	3.2e-05	0.00032	CcSEcCtD
Thalidomide—Malnutrition—Prednisone—ulcerative colitis	3.2e-05	0.000319	CcSEcCtD
Thalidomide—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	3.2e-05	0.000319	CcSEcCtD
Thalidomide—Hyperhidrosis—Triamcinolone—ulcerative colitis	3.2e-05	0.000319	CcSEcCtD
Thalidomide—Hyperhidrosis—Methylprednisolone—ulcerative colitis	3.19e-05	0.000318	CcSEcCtD
Thalidomide—Convulsion—Dexamethasone—ulcerative colitis	3.18e-05	0.000318	CcSEcCtD
Thalidomide—Convulsion—Betamethasone—ulcerative colitis	3.18e-05	0.000318	CcSEcCtD
Thalidomide—Insomnia—Hydrocortisone—ulcerative colitis	3.18e-05	0.000317	CcSEcCtD
Thalidomide—Hypertension—Dexamethasone—ulcerative colitis	3.17e-05	0.000317	CcSEcCtD
Thalidomide—Hypertension—Betamethasone—ulcerative colitis	3.17e-05	0.000317	CcSEcCtD
Thalidomide—Paraesthesia—Hydrocortisone—ulcerative colitis	3.15e-05	0.000315	CcSEcCtD
Thalidomide—Vomiting—Mesalazine—ulcerative colitis	3.14e-05	0.000313	CcSEcCtD
Thalidomide—Myalgia—Betamethasone—ulcerative colitis	3.13e-05	0.000312	CcSEcCtD
Thalidomide—Myalgia—Dexamethasone—ulcerative colitis	3.13e-05	0.000312	CcSEcCtD
Thalidomide—Anxiety—Dexamethasone—ulcerative colitis	3.12e-05	0.000311	CcSEcCtD
Thalidomide—Anxiety—Betamethasone—ulcerative colitis	3.12e-05	0.000311	CcSEcCtD
Thalidomide—Rash—Mesalazine—ulcerative colitis	3.11e-05	0.000311	CcSEcCtD
Thalidomide—Dermatitis—Mesalazine—ulcerative colitis	3.11e-05	0.00031	CcSEcCtD
Thalidomide—Headache—Mesalazine—ulcerative colitis	3.09e-05	0.000309	CcSEcCtD
Thalidomide—Discomfort—Betamethasone—ulcerative colitis	3.09e-05	0.000308	CcSEcCtD
Thalidomide—Discomfort—Dexamethasone—ulcerative colitis	3.09e-05	0.000308	CcSEcCtD
Thalidomide—Dyspepsia—Hydrocortisone—ulcerative colitis	3.09e-05	0.000308	CcSEcCtD
Thalidomide—Hypotension—Methylprednisolone—ulcerative colitis	3.08e-05	0.000308	CcSEcCtD
Thalidomide—Pain—Prednisolone—ulcerative colitis	3.07e-05	0.000307	CcSEcCtD
Thalidomide—Decreased appetite—Hydrocortisone—ulcerative colitis	3.05e-05	0.000304	CcSEcCtD
Thalidomide—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	3.03e-05	0.000302	CcSEcCtD
Thalidomide—Fatigue—Hydrocortisone—ulcerative colitis	3.03e-05	0.000302	CcSEcCtD
Thalidomide—Vision blurred—Prednisone—ulcerative colitis	3.02e-05	0.000301	CcSEcCtD
Thalidomide—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	3.01e-05	0.0003	CcSEcCtD
Thalidomide—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	3e-05	0.0003	CcSEcCtD
Thalidomide—Pain—Hydrocortisone—ulcerative colitis	3e-05	0.0003	CcSEcCtD
Thalidomide—Oedema—Betamethasone—ulcerative colitis	3e-05	0.000299	CcSEcCtD
Thalidomide—Oedema—Dexamethasone—ulcerative colitis	3e-05	0.000299	CcSEcCtD
Thalidomide—Insomnia—Triamcinolone—ulcerative colitis	2.99e-05	0.000298	CcSEcCtD
Thalidomide—Insomnia—Methylprednisolone—ulcerative colitis	2.98e-05	0.000298	CcSEcCtD
Thalidomide—Infection—Dexamethasone—ulcerative colitis	2.98e-05	0.000297	CcSEcCtD
Thalidomide—Infection—Betamethasone—ulcerative colitis	2.98e-05	0.000297	CcSEcCtD
Thalidomide—Ill-defined disorder—Prednisone—ulcerative colitis	2.97e-05	0.000296	CcSEcCtD
Thalidomide—Paraesthesia—Triamcinolone—ulcerative colitis	2.97e-05	0.000296	CcSEcCtD
Thalidomide—Feeling abnormal—Prednisolone—ulcerative colitis	2.96e-05	0.000296	CcSEcCtD
Thalidomide—Paraesthesia—Methylprednisolone—ulcerative colitis	2.96e-05	0.000296	CcSEcCtD
Thalidomide—Anaemia—Prednisone—ulcerative colitis	2.96e-05	0.000295	CcSEcCtD
Thalidomide—Shock—Betamethasone—ulcerative colitis	2.95e-05	0.000294	CcSEcCtD
Thalidomide—Shock—Dexamethasone—ulcerative colitis	2.95e-05	0.000294	CcSEcCtD
Thalidomide—Dyspnoea—Triamcinolone—ulcerative colitis	2.95e-05	0.000294	CcSEcCtD
Thalidomide—Nervous system disorder—Dexamethasone—ulcerative colitis	2.94e-05	0.000293	CcSEcCtD
Thalidomide—Nervous system disorder—Betamethasone—ulcerative colitis	2.94e-05	0.000293	CcSEcCtD
Thalidomide—Agitation—Prednisone—ulcerative colitis	2.94e-05	0.000293	CcSEcCtD
Thalidomide—Thrombocytopenia—Betamethasone—ulcerative colitis	2.94e-05	0.000293	CcSEcCtD
Thalidomide—Thrombocytopenia—Dexamethasone—ulcerative colitis	2.94e-05	0.000293	CcSEcCtD
Thalidomide—Nausea—Mesalazine—ulcerative colitis	2.93e-05	0.000293	CcSEcCtD
Thalidomide—Tachycardia—Dexamethasone—ulcerative colitis	2.93e-05	0.000292	CcSEcCtD
Thalidomide—Tachycardia—Betamethasone—ulcerative colitis	2.93e-05	0.000292	CcSEcCtD
Thalidomide—Angioedema—Prednisone—ulcerative colitis	2.92e-05	0.000292	CcSEcCtD
Thalidomide—Dyspepsia—Triamcinolone—ulcerative colitis	2.91e-05	0.00029	CcSEcCtD
Thalidomide—Dyspepsia—Methylprednisolone—ulcerative colitis	2.9e-05	0.00029	CcSEcCtD
Thalidomide—Hyperhidrosis—Dexamethasone—ulcerative colitis	2.9e-05	0.000289	CcSEcCtD
Thalidomide—Hyperhidrosis—Betamethasone—ulcerative colitis	2.9e-05	0.000289	CcSEcCtD
Thalidomide—Feeling abnormal—Hydrocortisone—ulcerative colitis	2.89e-05	0.000289	CcSEcCtD
Thalidomide—Malaise—Prednisone—ulcerative colitis	2.89e-05	0.000288	CcSEcCtD
Thalidomide—Vertigo—Prednisone—ulcerative colitis	2.88e-05	0.000287	CcSEcCtD
Thalidomide—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	2.87e-05	0.000286	CcSEcCtD
Thalidomide—Syncope—Prednisone—ulcerative colitis	2.87e-05	0.000286	CcSEcCtD
Thalidomide—Anorexia—Betamethasone—ulcerative colitis	2.86e-05	0.000285	CcSEcCtD
Thalidomide—Anorexia—Dexamethasone—ulcerative colitis	2.86e-05	0.000285	CcSEcCtD
Thalidomide—Urticaria—Prednisolone—ulcerative colitis	2.86e-05	0.000285	CcSEcCtD
Thalidomide—Fatigue—Triamcinolone—ulcerative colitis	2.85e-05	0.000284	CcSEcCtD
Thalidomide—Fatigue—Methylprednisolone—ulcerative colitis	2.84e-05	0.000284	CcSEcCtD
Thalidomide—Pain—Triamcinolone—ulcerative colitis	2.83e-05	0.000282	CcSEcCtD
Thalidomide—Loss of consciousness—Prednisone—ulcerative colitis	2.81e-05	0.000281	CcSEcCtD
Thalidomide—Hypotension—Betamethasone—ulcerative colitis	2.8e-05	0.00028	CcSEcCtD
Thalidomide—Hypotension—Dexamethasone—ulcerative colitis	2.8e-05	0.00028	CcSEcCtD
Thalidomide—Urticaria—Hydrocortisone—ulcerative colitis	2.79e-05	0.000278	CcSEcCtD
Thalidomide—Body temperature increased—Hydrocortisone—ulcerative colitis	2.78e-05	0.000277	CcSEcCtD
Thalidomide—Abdominal pain—Hydrocortisone—ulcerative colitis	2.78e-05	0.000277	CcSEcCtD
Thalidomide—Convulsion—Prednisone—ulcerative colitis	2.77e-05	0.000277	CcSEcCtD
Thalidomide—Hypertension—Prednisone—ulcerative colitis	2.76e-05	0.000276	CcSEcCtD
Thalidomide—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	2.73e-05	0.000273	CcSEcCtD
Thalidomide—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	2.73e-05	0.000273	CcSEcCtD
Thalidomide—Myalgia—Prednisone—ulcerative colitis	2.72e-05	0.000272	CcSEcCtD
Thalidomide—Arthralgia—Prednisone—ulcerative colitis	2.72e-05	0.000272	CcSEcCtD
Thalidomide—Feeling abnormal—Triamcinolone—ulcerative colitis	2.72e-05	0.000272	CcSEcCtD
Thalidomide—Feeling abnormal—Methylprednisolone—ulcerative colitis	2.72e-05	0.000271	CcSEcCtD
Thalidomide—Anxiety—Prednisone—ulcerative colitis	2.72e-05	0.000271	CcSEcCtD
Thalidomide—Insomnia—Betamethasone—ulcerative colitis	2.71e-05	0.000271	CcSEcCtD
Thalidomide—Insomnia—Dexamethasone—ulcerative colitis	2.71e-05	0.000271	CcSEcCtD
Thalidomide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	2.71e-05	0.00027	CcSEcCtD
Thalidomide—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	2.7e-05	0.000269	CcSEcCtD
Thalidomide—Paraesthesia—Dexamethasone—ulcerative colitis	2.69e-05	0.000269	CcSEcCtD
Thalidomide—Paraesthesia—Betamethasone—ulcerative colitis	2.69e-05	0.000269	CcSEcCtD
Thalidomide—Discomfort—Prednisone—ulcerative colitis	2.69e-05	0.000269	CcSEcCtD
Thalidomide—Hypersensitivity—Prednisolone—ulcerative colitis	2.65e-05	0.000264	CcSEcCtD
Thalidomide—Dyspepsia—Betamethasone—ulcerative colitis	2.64e-05	0.000263	CcSEcCtD
Thalidomide—Dyspepsia—Dexamethasone—ulcerative colitis	2.64e-05	0.000263	CcSEcCtD
Thalidomide—Urticaria—Triamcinolone—ulcerative colitis	2.63e-05	0.000262	CcSEcCtD
Thalidomide—Urticaria—Methylprednisolone—ulcerative colitis	2.62e-05	0.000261	CcSEcCtD
Thalidomide—Body temperature increased—Triamcinolone—ulcerative colitis	2.61e-05	0.000261	CcSEcCtD
Thalidomide—Oedema—Prednisone—ulcerative colitis	2.61e-05	0.000261	CcSEcCtD
Thalidomide—Abdominal pain—Methylprednisolone—ulcerative colitis	2.61e-05	0.00026	CcSEcCtD
Thalidomide—Decreased appetite—Dexamethasone—ulcerative colitis	2.61e-05	0.00026	CcSEcCtD
Thalidomide—Decreased appetite—Betamethasone—ulcerative colitis	2.61e-05	0.00026	CcSEcCtD
Thalidomide—Infection—Prednisone—ulcerative colitis	2.59e-05	0.000259	CcSEcCtD
Thalidomide—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	2.59e-05	0.000258	CcSEcCtD
Thalidomide—Gastrointestinal disorder—Betamethasone—ulcerative colitis	2.59e-05	0.000258	CcSEcCtD
Thalidomide—Hypersensitivity—Hydrocortisone—ulcerative colitis	2.59e-05	0.000258	CcSEcCtD
Thalidomide—Fatigue—Betamethasone—ulcerative colitis	2.59e-05	0.000258	CcSEcCtD
Thalidomide—Fatigue—Dexamethasone—ulcerative colitis	2.59e-05	0.000258	CcSEcCtD
Thalidomide—Shock—Prednisone—ulcerative colitis	2.57e-05	0.000256	CcSEcCtD
Thalidomide—Pain—Betamethasone—ulcerative colitis	2.56e-05	0.000256	CcSEcCtD
Thalidomide—Pain—Dexamethasone—ulcerative colitis	2.56e-05	0.000256	CcSEcCtD
Thalidomide—Nervous system disorder—Prednisone—ulcerative colitis	2.56e-05	0.000256	CcSEcCtD
Thalidomide—Tachycardia—Prednisone—ulcerative colitis	2.55e-05	0.000254	CcSEcCtD
Thalidomide—Skin disorder—Prednisone—ulcerative colitis	2.54e-05	0.000253	CcSEcCtD
Thalidomide—Hyperhidrosis—Prednisone—ulcerative colitis	2.52e-05	0.000252	CcSEcCtD
Thalidomide—Asthenia—Hydrocortisone—ulcerative colitis	2.52e-05	0.000251	CcSEcCtD
Thalidomide—Anorexia—Prednisone—ulcerative colitis	2.49e-05	0.000248	CcSEcCtD
Thalidomide—Pruritus—Hydrocortisone—ulcerative colitis	2.48e-05	0.000248	CcSEcCtD
Thalidomide—Feeling abnormal—Dexamethasone—ulcerative colitis	2.47e-05	0.000247	CcSEcCtD
Thalidomide—Feeling abnormal—Betamethasone—ulcerative colitis	2.47e-05	0.000247	CcSEcCtD
Thalidomide—Gastrointestinal pain—Dexamethasone—ulcerative colitis	2.45e-05	0.000245	CcSEcCtD
Thalidomide—Gastrointestinal pain—Betamethasone—ulcerative colitis	2.45e-05	0.000245	CcSEcCtD
Thalidomide—Hypersensitivity—Triamcinolone—ulcerative colitis	2.44e-05	0.000243	CcSEcCtD
Thalidomide—Hypersensitivity—Methylprednisolone—ulcerative colitis	2.43e-05	0.000242	CcSEcCtD
Thalidomide—Diarrhoea—Hydrocortisone—ulcerative colitis	2.4e-05	0.00024	CcSEcCtD
Thalidomide—Urticaria—Dexamethasone—ulcerative colitis	2.38e-05	0.000238	CcSEcCtD
Thalidomide—Urticaria—Betamethasone—ulcerative colitis	2.38e-05	0.000238	CcSEcCtD
Thalidomide—Musculoskeletal discomfort—Prednisone—ulcerative colitis	2.38e-05	0.000237	CcSEcCtD
Thalidomide—Dizziness—Prednisolone—ulcerative colitis	2.38e-05	0.000237	CcSEcCtD
Thalidomide—Asthenia—Triamcinolone—ulcerative colitis	2.37e-05	0.000237	CcSEcCtD
Thalidomide—Body temperature increased—Betamethasone—ulcerative colitis	2.37e-05	0.000237	CcSEcCtD
Thalidomide—Body temperature increased—Dexamethasone—ulcerative colitis	2.37e-05	0.000237	CcSEcCtD
Thalidomide—Abdominal pain—Dexamethasone—ulcerative colitis	2.37e-05	0.000237	CcSEcCtD
Thalidomide—Abdominal pain—Betamethasone—ulcerative colitis	2.37e-05	0.000237	CcSEcCtD
Thalidomide—Asthenia—Methylprednisolone—ulcerative colitis	2.37e-05	0.000236	CcSEcCtD
Thalidomide—Insomnia—Prednisone—ulcerative colitis	2.36e-05	0.000236	CcSEcCtD
Thalidomide—Paraesthesia—Prednisone—ulcerative colitis	2.35e-05	0.000234	CcSEcCtD
Thalidomide—Pruritus—Triamcinolone—ulcerative colitis	2.34e-05	0.000233	CcSEcCtD
Thalidomide—Pruritus—Methylprednisolone—ulcerative colitis	2.33e-05	0.000233	CcSEcCtD
Thalidomide—Dizziness—Hydrocortisone—ulcerative colitis	2.32e-05	0.000232	CcSEcCtD
Thalidomide—Dyspepsia—Prednisone—ulcerative colitis	2.3e-05	0.000229	CcSEcCtD
Thalidomide—Decreased appetite—Prednisone—ulcerative colitis	2.27e-05	0.000227	CcSEcCtD
Thalidomide—Rash—Prednisolone—ulcerative colitis	2.27e-05	0.000226	CcSEcCtD
Thalidomide—Dermatitis—Prednisolone—ulcerative colitis	2.26e-05	0.000226	CcSEcCtD
Thalidomide—Diarrhoea—Methylprednisolone—ulcerative colitis	2.26e-05	0.000225	CcSEcCtD
Thalidomide—Fatigue—Prednisone—ulcerative colitis	2.25e-05	0.000225	CcSEcCtD
Thalidomide—Headache—Prednisolone—ulcerative colitis	2.25e-05	0.000225	CcSEcCtD
Thalidomide—Constipation—Prednisone—ulcerative colitis	2.23e-05	0.000223	CcSEcCtD
Thalidomide—Vomiting—Hydrocortisone—ulcerative colitis	2.23e-05	0.000223	CcSEcCtD
Thalidomide—Rash—Hydrocortisone—ulcerative colitis	2.21e-05	0.000221	CcSEcCtD
Thalidomide—Dermatitis—Hydrocortisone—ulcerative colitis	2.21e-05	0.000221	CcSEcCtD
Thalidomide—Headache—Hydrocortisone—ulcerative colitis	2.2e-05	0.000219	CcSEcCtD
Thalidomide—Dizziness—Triamcinolone—ulcerative colitis	2.19e-05	0.000218	CcSEcCtD
Thalidomide—Dizziness—Methylprednisolone—ulcerative colitis	2.18e-05	0.000218	CcSEcCtD
Thalidomide—Feeling abnormal—Prednisone—ulcerative colitis	2.15e-05	0.000215	CcSEcCtD
Thalidomide—Asthenia—Betamethasone—ulcerative colitis	2.15e-05	0.000215	CcSEcCtD
Thalidomide—Asthenia—Dexamethasone—ulcerative colitis	2.15e-05	0.000215	CcSEcCtD
Thalidomide—Gastrointestinal pain—Prednisone—ulcerative colitis	2.14e-05	0.000213	CcSEcCtD
Thalidomide—Nausea—Prednisolone—ulcerative colitis	2.13e-05	0.000213	CcSEcCtD
Thalidomide—Pruritus—Dexamethasone—ulcerative colitis	2.12e-05	0.000212	CcSEcCtD
Thalidomide—Pruritus—Betamethasone—ulcerative colitis	2.12e-05	0.000212	CcSEcCtD
Thalidomide—Vomiting—Triamcinolone—ulcerative colitis	2.1e-05	0.00021	CcSEcCtD
Thalidomide—Vomiting—Methylprednisolone—ulcerative colitis	2.1e-05	0.000209	CcSEcCtD
Thalidomide—Nausea—Hydrocortisone—ulcerative colitis	2.09e-05	0.000208	CcSEcCtD
Thalidomide—Rash—Triamcinolone—ulcerative colitis	2.08e-05	0.000208	CcSEcCtD
Thalidomide—Dermatitis—Triamcinolone—ulcerative colitis	2.08e-05	0.000208	CcSEcCtD
Thalidomide—Rash—Methylprednisolone—ulcerative colitis	2.08e-05	0.000207	CcSEcCtD
Thalidomide—Dermatitis—Methylprednisolone—ulcerative colitis	2.08e-05	0.000207	CcSEcCtD
Thalidomide—Urticaria—Prednisone—ulcerative colitis	2.07e-05	0.000207	CcSEcCtD
Thalidomide—Headache—Triamcinolone—ulcerative colitis	2.07e-05	0.000207	CcSEcCtD
Thalidomide—Headache—Methylprednisolone—ulcerative colitis	2.07e-05	0.000206	CcSEcCtD
Thalidomide—Body temperature increased—Prednisone—ulcerative colitis	2.06e-05	0.000206	CcSEcCtD
Thalidomide—Abdominal pain—Prednisone—ulcerative colitis	2.06e-05	0.000206	CcSEcCtD
Thalidomide—Diarrhoea—Dexamethasone—ulcerative colitis	2.05e-05	0.000205	CcSEcCtD
Thalidomide—Diarrhoea—Betamethasone—ulcerative colitis	2.05e-05	0.000205	CcSEcCtD
Thalidomide—Dizziness—Dexamethasone—ulcerative colitis	1.98e-05	0.000198	CcSEcCtD
Thalidomide—Dizziness—Betamethasone—ulcerative colitis	1.98e-05	0.000198	CcSEcCtD
Thalidomide—Nausea—Triamcinolone—ulcerative colitis	1.96e-05	0.000196	CcSEcCtD
Thalidomide—Nausea—Methylprednisolone—ulcerative colitis	1.96e-05	0.000195	CcSEcCtD
Thalidomide—Hypersensitivity—Prednisone—ulcerative colitis	1.92e-05	0.000192	CcSEcCtD
Thalidomide—Vomiting—Dexamethasone—ulcerative colitis	1.91e-05	0.00019	CcSEcCtD
Thalidomide—Vomiting—Betamethasone—ulcerative colitis	1.91e-05	0.00019	CcSEcCtD
Thalidomide—Rash—Betamethasone—ulcerative colitis	1.89e-05	0.000189	CcSEcCtD
Thalidomide—Rash—Dexamethasone—ulcerative colitis	1.89e-05	0.000189	CcSEcCtD
Thalidomide—Dermatitis—Dexamethasone—ulcerative colitis	1.89e-05	0.000189	CcSEcCtD
Thalidomide—Dermatitis—Betamethasone—ulcerative colitis	1.89e-05	0.000189	CcSEcCtD
Thalidomide—Headache—Betamethasone—ulcerative colitis	1.88e-05	0.000187	CcSEcCtD
Thalidomide—Headache—Dexamethasone—ulcerative colitis	1.88e-05	0.000187	CcSEcCtD
Thalidomide—Asthenia—Prednisone—ulcerative colitis	1.87e-05	0.000187	CcSEcCtD
Thalidomide—Pruritus—Prednisone—ulcerative colitis	1.85e-05	0.000184	CcSEcCtD
Thalidomide—Diarrhoea—Prednisone—ulcerative colitis	1.79e-05	0.000178	CcSEcCtD
Thalidomide—Nausea—Dexamethasone—ulcerative colitis	1.78e-05	0.000178	CcSEcCtD
Thalidomide—Nausea—Betamethasone—ulcerative colitis	1.78e-05	0.000178	CcSEcCtD
Thalidomide—Dizziness—Prednisone—ulcerative colitis	1.73e-05	0.000172	CcSEcCtD
Thalidomide—Vomiting—Prednisone—ulcerative colitis	1.66e-05	0.000166	CcSEcCtD
Thalidomide—Rash—Prednisone—ulcerative colitis	1.65e-05	0.000164	CcSEcCtD
Thalidomide—Dermatitis—Prednisone—ulcerative colitis	1.65e-05	0.000164	CcSEcCtD
Thalidomide—Headache—Prednisone—ulcerative colitis	1.64e-05	0.000163	CcSEcCtD
Thalidomide—Nausea—Prednisone—ulcerative colitis	1.55e-05	0.000155	CcSEcCtD
Thalidomide—NFKB1—Immune System—CTLA4—ulcerative colitis	1.41e-05	0.000182	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—CHP1—ulcerative colitis	1.41e-05	0.000182	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by EGFR—IL6—ulcerative colitis	1.4e-05	0.00018	CbGpPWpGaD
Thalidomide—NFKB1—Adaptive Immune System—ICAM1—ulcerative colitis	1.4e-05	0.00018	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by EGFR in Cancer—IL6—ulcerative colitis	1.39e-05	0.000179	CbGpPWpGaD
Thalidomide—FGFR2—Adaptive Immune System—HLA-DRB1—ulcerative colitis	1.38e-05	0.000178	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by PDGF—IL6—ulcerative colitis	1.38e-05	0.000178	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—CALM3—ulcerative colitis	1.38e-05	0.000178	CbGpPWpGaD
Thalidomide—TNF—Apoptosis—TP53—ulcerative colitis	1.38e-05	0.000178	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by NGF—STAT3—ulcerative colitis	1.38e-05	0.000178	CbGpPWpGaD
Thalidomide—TNF—Regulation of toll-like receptor signaling pathway—IL6—ulcerative colitis	1.38e-05	0.000177	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—CCL20—ulcerative colitis	1.36e-05	0.000176	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—RIPK2—ulcerative colitis	1.36e-05	0.000175	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—GNA12—ulcerative colitis	1.35e-05	0.000174	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—CD79A—ulcerative colitis	1.34e-05	0.000173	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—CTLA4—ulcerative colitis	1.34e-05	0.000173	CbGpPWpGaD
Thalidomide—PTGS2—Disease—SEL1L—ulcerative colitis	1.34e-05	0.000172	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—CHP1—ulcerative colitis	1.33e-05	0.000171	CbGpPWpGaD
Thalidomide—FGFR2—Adaptive Immune System—ICAM1—ulcerative colitis	1.33e-05	0.000171	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—CHP1—ulcerative colitis	1.32e-05	0.000171	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.32e-05	0.00017	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—NOD2—ulcerative colitis	1.3e-05	0.000167	CbGpPWpGaD
Thalidomide—TNF—MAPK Signaling Pathway—TP53—ulcerative colitis	1.29e-05	0.000167	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—CD14—ulcerative colitis	1.29e-05	0.000166	CbGpPWpGaD
Thalidomide—PTGS2—Spinal Cord Injury—TGFB1—ulcerative colitis	1.29e-05	0.000166	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—GNA12—ulcerative colitis	1.28e-05	0.000165	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—CXCR2—ulcerative colitis	1.28e-05	0.000165	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—JAK2—ulcerative colitis	1.28e-05	0.000165	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—CD79A—ulcerative colitis	1.28e-05	0.000165	CbGpPWpGaD
Thalidomide—FGFR2—Disease—CALM3—ulcerative colitis	1.27e-05	0.000164	CbGpPWpGaD
Thalidomide—TNF—SIDS Susceptibility Pathways—IL6—ulcerative colitis	1.25e-05	0.000162	CbGpPWpGaD
Thalidomide—FGFR2—NGF signalling via TRKA from the plasma membrane—IL6—ulcerative colitis	1.25e-05	0.000161	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—CHP1—ulcerative colitis	1.25e-05	0.000161	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—VCAM1—ulcerative colitis	1.24e-05	0.00016	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—HLA-DQA1—ulcerative colitis	1.24e-05	0.00016	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—RELA—ulcerative colitis	1.24e-05	0.000159	CbGpPWpGaD
Thalidomide—NFKB1—Adaptive Immune System—CDH1—ulcerative colitis	1.24e-05	0.000159	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—NOD2—ulcerative colitis	1.23e-05	0.000159	CbGpPWpGaD
Thalidomide—PTGS2—Selenium Micronutrient Network—IL6—ulcerative colitis	1.23e-05	0.000158	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—CD14—ulcerative colitis	1.22e-05	0.000158	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—DLD—ulcerative colitis	1.22e-05	0.000157	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—CXCR2—ulcerative colitis	1.21e-05	0.000157	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—CCR6—ulcerative colitis	1.2e-05	0.000155	CbGpPWpGaD
Thalidomide—PTGS2—Spinal Cord Injury—TNF—ulcerative colitis	1.2e-05	0.000155	CbGpPWpGaD
Thalidomide—PTGS2—Disease—LTF—ulcerative colitis	1.2e-05	0.000155	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—VCAM1—ulcerative colitis	1.18e-05	0.000152	CbGpPWpGaD
Thalidomide—NFKB1—Cellular responses to stress—TP53—ulcerative colitis	1.18e-05	0.000152	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—HLA-DQA1—ulcerative colitis	1.18e-05	0.000152	CbGpPWpGaD
Thalidomide—FGFR2—Adaptive Immune System—CDH1—ulcerative colitis	1.17e-05	0.000151	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.17e-05	0.000151	CbGpPWpGaD
Thalidomide—TNF—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.17e-05	0.00015	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—PPARG—ulcerative colitis	1.16e-05	0.00015	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—DLD—ulcerative colitis	1.14e-05	0.000148	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—DLD—ulcerative colitis	1.14e-05	0.000147	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—CCR6—ulcerative colitis	1.14e-05	0.000147	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—MAML2—ulcerative colitis	1.14e-05	0.000147	CbGpPWpGaD
Thalidomide—NFKB1—Innate Immune System—JAK2—ulcerative colitis	1.13e-05	0.000145	CbGpPWpGaD
Thalidomide—NFKB1—Innate Immune System—RELA—ulcerative colitis	1.09e-05	0.000141	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—MAML2—ulcerative colitis	1.08e-05	0.00014	CbGpPWpGaD
Thalidomide—NFKB1—Cellular responses to stress—IL6—ulcerative colitis	1.08e-05	0.000139	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—DLD—ulcerative colitis	1.08e-05	0.000139	CbGpPWpGaD
Thalidomide—FGFR2—Innate Immune System—JAK2—ulcerative colitis	1.07e-05	0.000138	CbGpPWpGaD
Thalidomide—NFKB1—Innate Immune System—CD4—ulcerative colitis	1.07e-05	0.000138	CbGpPWpGaD
Thalidomide—PTGS2—Spinal Cord Injury—TP53—ulcerative colitis	1.06e-05	0.000137	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—PTGER4—ulcerative colitis	1.06e-05	0.000137	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—MMP9—ulcerative colitis	1.05e-05	0.000136	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—ADCY5—ulcerative colitis	1.05e-05	0.000136	CbGpPWpGaD
Thalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	1.05e-05	0.000136	CbGpPWpGaD
Thalidomide—NFKB1—Adaptive Immune System—RELA—ulcerative colitis	1.05e-05	0.000135	CbGpPWpGaD
Thalidomide—FGFR2—Innate Immune System—RELA—ulcerative colitis	1.04e-05	0.000134	CbGpPWpGaD
Thalidomide—NFKB1—Cytokine Signaling in Immune system—IL6—ulcerative colitis	1.03e-05	0.000133	CbGpPWpGaD
Thalidomide—NFKB1—Adaptive Immune System—CD4—ulcerative colitis	1.03e-05	0.000132	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—CHP1—ulcerative colitis	1.02e-05	0.000132	CbGpPWpGaD
Thalidomide—FGFR2—Innate Immune System—CD4—ulcerative colitis	1.01e-05	0.000131	CbGpPWpGaD
Thalidomide—NFKB1—Signaling by NGF—IL6—ulcerative colitis	1.01e-05	0.000131	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—PTGER4—ulcerative colitis	1e-05	0.00013	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—ADCY5—ulcerative colitis	1e-05	0.000129	CbGpPWpGaD
Thalidomide—FGFR2—Adaptive Immune System—RELA—ulcerative colitis	9.95e-06	0.000128	CbGpPWpGaD
Thalidomide—FGFR2—Adaptive Immune System—CD4—ulcerative colitis	9.74e-06	0.000126	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—JAK2—ulcerative colitis	9.73e-06	0.000125	CbGpPWpGaD
Thalidomide—PTGS2—Spinal Cord Injury—IL6—ulcerative colitis	9.7e-06	0.000125	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—GHRL—ulcerative colitis	9.69e-06	0.000125	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by NGF—IL6—ulcerative colitis	9.62e-06	0.000124	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	9.58e-06	0.000124	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—RELA—ulcerative colitis	9.42e-06	0.000122	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—CALM3—ulcerative colitis	9.39e-06	0.000121	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—STAT3—ulcerative colitis	9.37e-06	0.000121	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—CHP1—ulcerative colitis	9.32e-06	0.00012	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—RIPK2—ulcerative colitis	9.25e-06	0.000119	CbGpPWpGaD
Thalidomide—FGFR2—Disease—ADCY5—ulcerative colitis	9.23e-06	0.000119	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—CRP—ulcerative colitis	9.22e-06	0.000119	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—GHRL—ulcerative colitis	9.2e-06	0.000119	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—CALM3—ulcerative colitis	8.91e-06	0.000115	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—TLR4—ulcerative colitis	8.84e-06	0.000114	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—DLD—ulcerative colitis	8.83e-06	0.000114	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—HLA-DRB1—ulcerative colitis	8.83e-06	0.000114	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—RIPK2—ulcerative colitis	8.77e-06	0.000113	CbGpPWpGaD
Thalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	8.75e-06	0.000113	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—CRP—ulcerative colitis	8.75e-06	0.000113	CbGpPWpGaD
Thalidomide—FGFR2—Innate Immune System—NFKB1—ulcerative colitis	8.74e-06	0.000113	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	8.74e-06	0.000113	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—TGFB1—ulcerative colitis	8.69e-06	0.000112	CbGpPWpGaD
Thalidomide—PTGS2—Disease—SLC11A1—ulcerative colitis	8.54e-06	0.00011	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—ICAM1—ulcerative colitis	8.47e-06	0.000109	CbGpPWpGaD
Thalidomide—FGFR2—Adaptive Immune System—NFKB1—ulcerative colitis	8.39e-06	0.000108	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—TLR4—ulcerative colitis	8.38e-06	0.000108	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—HLA-DRB1—ulcerative colitis	8.38e-06	0.000108	CbGpPWpGaD
Thalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	8.17e-06	0.000105	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—TNF—ulcerative colitis	8.11e-06	0.000105	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	8.1e-06	0.000104	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—DLD—ulcerative colitis	8.05e-06	0.000104	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—ICAM1—ulcerative colitis	8.04e-06	0.000104	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—MMP9—ulcerative colitis	8.03e-06	0.000104	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—ADRB2—ulcerative colitis	8.02e-06	0.000103	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—CHP1—ulcerative colitis	7.97e-06	0.000103	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—NFKB1—ulcerative colitis	7.95e-06	0.000102	CbGpPWpGaD
Thalidomide—PTGS2—Disease—MAML2—ulcerative colitis	7.67e-06	9.89e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—ADRB2—ulcerative colitis	7.61e-06	9.82e-05	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—CDH1—ulcerative colitis	7.49e-06	9.66e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	7.47e-06	9.63e-05	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	7.28e-06	9.39e-05	CbGpPWpGaD
Thalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	7.21e-06	9.29e-05	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—STAT3—ulcerative colitis	7.14e-06	9.21e-05	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—CDH1—ulcerative colitis	7.11e-06	9.17e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—DLD—ulcerative colitis	6.88e-06	8.87e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—ADCY5—ulcerative colitis	6.81e-06	8.78e-05	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—CALM3—ulcerative colitis	6.66e-06	8.6e-05	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—TGFB1—ulcerative colitis	6.62e-06	8.54e-05	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—JAK2—ulcerative colitis	6.57e-06	8.47e-05	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—IL6—ulcerative colitis	6.55e-06	8.44e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—ADCY5—ulcerative colitis	6.46e-06	8.33e-05	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—IFNG—ulcerative colitis	6.45e-06	8.31e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	6.43e-06	8.29e-05	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	6.37e-06	8.21e-05	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—RELA—ulcerative colitis	6.36e-06	8.2e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—CALM3—ulcerative colitis	6.32e-06	8.15e-05	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—JAK2—ulcerative colitis	6.23e-06	8.04e-05	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—CD4—ulcerative colitis	6.23e-06	8.03e-05	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—IFNG—ulcerative colitis	6.12e-06	7.89e-05	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—RELA—ulcerative colitis	6.04e-06	7.78e-05	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—CD4—ulcerative colitis	5.91e-06	7.62e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—PTGS1—ulcerative colitis	5.88e-06	7.58e-05	CbGpPWpGaD
Thalidomide—NFKB1—Innate Immune System—IL6—ulcerative colitis	5.78e-06	7.46e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	5.78e-06	7.45e-05	CbGpPWpGaD
Thalidomide—FGFR2—Disease—JAK2—ulcerative colitis	5.75e-06	7.42e-05	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—IL1B—ulcerative colitis	5.75e-06	7.42e-05	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—IL2—ulcerative colitis	5.73e-06	7.39e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	5.7e-06	7.36e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—PTGS1—ulcerative colitis	5.53e-06	7.13e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—PTGS1—ulcerative colitis	5.52e-06	7.12e-05	CbGpPWpGaD
Thalidomide—FGFR2—Innate Immune System—IL6—ulcerative colitis	5.49e-06	7.07e-05	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—IL1B—ulcerative colitis	5.46e-06	7.04e-05	CbGpPWpGaD
Thalidomide—FGFR2—Disease—CD4—ulcerative colitis	5.45e-06	7.03e-05	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—IL2—ulcerative colitis	5.44e-06	7.01e-05	CbGpPWpGaD
Thalidomide—FGFR2—Disease—PTGS2—ulcerative colitis	5.41e-06	6.98e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—CALM3—ulcerative colitis	5.29e-06	6.82e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—PTGS1—ulcerative colitis	5.22e-06	6.73e-05	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—ABCB1—ulcerative colitis	5.18e-06	6.68e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	5.13e-06	6.62e-05	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—NFKB1—ulcerative colitis	5.09e-06	6.56e-05	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—IL6—ulcerative colitis	4.99e-06	6.43e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—CALM3—ulcerative colitis	4.98e-06	6.42e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—CALM3—ulcerative colitis	4.97e-06	6.41e-05	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—ADCY5—ulcerative colitis	4.83e-06	6.24e-05	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—STAT3—ulcerative colitis	4.82e-06	6.22e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—CALM3—ulcerative colitis	4.7e-06	6.06e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	4.67e-06	6.02e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—ADCY5—ulcerative colitis	4.58e-06	5.91e-05	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—STAT3—ulcerative colitis	4.57e-06	5.9e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	4.49e-06	5.79e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—PTGS1—ulcerative colitis	4.27e-06	5.5e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	4.26e-06	5.49e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—JAK2—ulcerative colitis	4.25e-06	5.48e-05	CbGpPWpGaD
Thalidomide—FGFR2—Disease—STAT3—ulcerative colitis	4.22e-06	5.45e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	4.2e-06	5.41e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—ABCB1—ulcerative colitis	4.11e-06	5.31e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—RELA—ulcerative colitis	4.11e-06	5.3e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—JAK2—ulcerative colitis	4.03e-06	5.2e-05	CbGpPWpGaD
Thalidomide—FGFR2—Disease—TGFB1—ulcerative colitis	3.91e-06	5.05e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—RELA—ulcerative colitis	3.9e-06	5.03e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—PTGS1—ulcerative colitis	3.89e-06	5.02e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—CXCL8—ulcerative colitis	3.88e-06	5e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—ABCB1—ulcerative colitis	3.87e-06	5e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—ABCB1—ulcerative colitis	3.87e-06	4.98e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—CALM3—ulcerative colitis	3.84e-06	4.96e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—ADCY5—ulcerative colitis	3.84e-06	4.95e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	3.83e-06	4.94e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—IL2—ulcerative colitis	3.7e-06	4.78e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—CXCL8—ulcerative colitis	3.68e-06	4.74e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	3.67e-06	4.74e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—ABCB1—ulcerative colitis	3.65e-06	4.71e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	3.64e-06	4.69e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—ADCY5—ulcerative colitis	3.61e-06	4.66e-05	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—PPARG—ulcerative colitis	3.61e-06	4.65e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—ADCY5—ulcerative colitis	3.61e-06	4.65e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—IL2—ulcerative colitis	3.51e-06	4.53e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—MMP9—ulcerative colitis	3.51e-06	4.52e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—CALM3—ulcerative colitis	3.5e-06	4.52e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—ADCY5—ulcerative colitis	3.41e-06	4.39e-05	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—IL6—ulcerative colitis	3.37e-06	4.34e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	3.35e-06	4.32e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—MMP9—ulcerative colitis	3.33e-06	4.29e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—PTGS1—ulcerative colitis	3.33e-06	4.29e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—NFKB1—ulcerative colitis	3.29e-06	4.24e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	3.27e-06	4.22e-05	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—ALB—ulcerative colitis	3.24e-06	4.18e-05	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—IL6—ulcerative colitis	3.19e-06	4.12e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—STAT3—ulcerative colitis	3.12e-06	4.02e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—CALM3—ulcerative colitis	2.99e-06	3.86e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—ABCB1—ulcerative colitis	2.99e-06	3.85e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—STAT3—ulcerative colitis	2.96e-06	3.81e-05	CbGpPWpGaD
Thalidomide—FGFR2—Disease—IL6—ulcerative colitis	2.95e-06	3.8e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—TGFB1—ulcerative colitis	2.89e-06	3.73e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—PPARG—ulcerative colitis	2.86e-06	3.69e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	2.86e-06	3.69e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—JAK2—ulcerative colitis	2.86e-06	3.68e-05	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—PTGS2—ulcerative colitis	2.84e-06	3.66e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—ADCY5—ulcerative colitis	2.79e-06	3.6e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—TGFB1—ulcerative colitis	2.74e-06	3.54e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—ABCB1—ulcerative colitis	2.72e-06	3.51e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—CD4—ulcerative colitis	2.71e-06	3.49e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—PPARG—ulcerative colitis	2.69e-06	3.48e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—PPARG—ulcerative colitis	2.69e-06	3.47e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—ALB—ulcerative colitis	2.57e-06	3.32e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—ADCY5—ulcerative colitis	2.54e-06	3.28e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—PPARG—ulcerative colitis	2.54e-06	3.28e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—ALB—ulcerative colitis	2.42e-06	3.12e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—ALB—ulcerative colitis	2.42e-06	3.12e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—TP53—ulcerative colitis	2.38e-06	3.07e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—ABCB1—ulcerative colitis	2.33e-06	3e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—ALB—ulcerative colitis	2.28e-06	2.95e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—TP53—ulcerative colitis	2.26e-06	2.91e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—IL6—ulcerative colitis	2.18e-06	2.81e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—ADCY5—ulcerative colitis	2.17e-06	2.8e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—PTGS2—ulcerative colitis	2.12e-06	2.73e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—PTGS2—ulcerative colitis	2.12e-06	2.73e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—STAT3—ulcerative colitis	2.1e-06	2.7e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—PPARG—ulcerative colitis	2.08e-06	2.68e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—IL6—ulcerative colitis	2.07e-06	2.66e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—PTGS2—ulcerative colitis	2e-06	2.58e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—TGFB1—ulcerative colitis	1.94e-06	2.51e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—PPARG—ulcerative colitis	1.9e-06	2.44e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—ALB—ulcerative colitis	1.87e-06	2.41e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—ALB—ulcerative colitis	1.7e-06	2.2e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—PTGS2—ulcerative colitis	1.64e-06	2.11e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—PPARG—ulcerative colitis	1.62e-06	2.09e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—PTGS2—ulcerative colitis	1.49e-06	1.92e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—IL6—ulcerative colitis	1.46e-06	1.89e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—ALB—ulcerative colitis	1.46e-06	1.88e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—PTGS2—ulcerative colitis	1.27e-06	1.64e-05	CbGpPWpGaD
